Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
Meletios A. Dimopoulos; María Victoria Mateos ; Paul G. Richardson; Rudolf Schlag; Nuriet K. Khuageva; Ofer Shpilberg; Martin Kropff; Ivan Spicka; Antonio Palumbo; Ka Lung Wu; Dixie-Lee Esseltine; Kevin Liu; William Deraedt; Andrew Cakana; Helgi van de Velde; Jesús Fernando San Miguel Izquierdo
European Journal Of Haematology 86: 23-31. FI: 2,785(Q2)